Rockwell Automation Inc (NYSE: ROK), an industrial automation and digital transformation company, on Tuesday revealed the adoption of FactoryTalk PharmaSuite MES by Rottendorf Pharma GmbH. This comprehensive electronic batch recording solution promises increased accuracy, quality, efficiency and repeatability, laying the groundwork for future digitalisation endeavors. The deployment aims to optimise day-to-day metrics, multi-customer batch control, and global software validation.
Headquartered in Ennigerloh, Germany, Rottendorf Pharma operates as a global CDMO with expertise in solid-dosage-form production. Embracing Total Process Ownership (TPO) and Total Technological Mastering (TTM) philosophies, the company streamlines customer management, reduces costs and enhances supply chains and product quality.
The deployment of FactoryTalk PharmaSuite MES at Rottendorf Pharma extends beyond operational enhancements, providing consistent weigh-and-dispense data for central weighing operations. This marks the initial step in achieving end-to-end electronic batch recording throughout the pharma value chain.
Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs around 29,000 professionals across more than 100 countries.
Rottendorf Pharma, with over 95 years of experience, offers a diverse portfolio of original and generic drugs, backed by a workforce of over 1,300 experts.
Viatris names new chief legal officer
Alvotech signs biosimilar supply and commercialisation deals with Sandoz
InSysBio agrees new collaborative project with BeOne Medicines
MS Pharma enters strategic partnership with Hetero Group
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic
ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA
Accord Healthcare launches Clomiphene tablets in US market
Zentiva receives ESG Transparency Award 2025
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
EirGenix signs second global exclusive licensing deal with Sandoz